This is for instance the case for the Ndufs4−/− mouse model of Leigh syndrome for which previous attempts of gene replacement therapy using an AAV9-Ndusf4 vector in neonates did not show significant effects (Di Meo et al., 2017). Here, NDUFS4 is linked to Leigh syndrome.